Kad\u0131n sa\u011fl\u0131\u011f\u0131 ve kanserle m\u00fccadelede fark\u0131ndal\u0131k olu\u015fturmak amac\u0131yla Medicana International \u0130zmir Hastanesi\u2019nde, “Kad\u0131n doktorlar kad\u0131n kanserlerini konu\u015fuyor” ba\u015fl\u0131kl\u0131 bir s\u00f6yle\u015fi d\u00fczenlendi.
\n
Medicana International \u0130zmir Hastanesi, \u2018Kad\u0131n doktorlar kad\u0131n kanserlerini konu\u015fuyor\u2019 ba\u015fl\u0131kl\u0131 s\u00f6yle\u015fiye ev sahipli\u011fi yapt\u0131 Medicana International \u0130zmir Hastanesi Medikal Onkoloji B\u00f6l\u00fcm\u00fc\u2019nden Do\u00e7. Dr. G\u00fclcan Bulut\u2019un moderat\u00f6rl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131, onkoloji hastalar\u0131n\u0131n da kat\u0131ld\u0131\u011f\u0131 s\u00f6yle\u015fide, Medikal Onkoloji Uzman\u0131 Prof. Dr. L\u00fctfiye Demir, Kad\u0131n Hastal\u0131klar\u0131 ve Do\u011fum Uzman\u0131 Op. Dr. \u0130lkay Nafiye Topalo\u011flu, Radyasyon Onkolojisi Uzman\u0131 Dr. \u00c7imen Ak\u00e7ay, Psikiyatrist Dr. \u00d6\u011fretim \u00dcyesi M\u00fcge Ya\u015far ve Radyoloji Uzman\u0131 Dr. Feray Sara\u00e7o\u011flu konu\u015fmac\u0131 olarak yer ald\u0131.
\n
“Kad\u0131nlar hayat\u0131n her alan\u0131nda b\u00fcy\u00fck sorumluluklar \u00fcstlenirken kendi sa\u011fl\u0131klar\u0131n\u0131 \u00e7o\u011fu zaman ikinci plana atabiliyorlar. Oysa erken te\u015fhis ve bilin\u00e7lenme kad\u0131n kanserleriyle m\u00fccadelede en \u00f6nemli silahlar\u0131m\u0131zdan biridir” diyen Do\u00e7. Dr. G\u00fclcan Bulut, “Uzmanlar\u0131m\u0131z\u0131n de\u011ferli bilgileriyle bu m\u00fccadelede neler yapabilece\u011fimizi daha iyi anl\u0131yoruz. \u00c7\u00fcnk\u00fc bilin\u00e7lenmek, g\u00fc\u00e7lenmek demektir. Unutmayal\u0131m ki sa\u011fl\u0131k ihmale gelmez. Her kad\u0131n sa\u011fl\u0131kl\u0131 bir ya\u015fam\u0131 hak eder” dedi. Mart ay\u0131n\u0131n Kolon Kanseri Fark\u0131ndal\u0131k Ay\u0131 oldu\u011funu hat\u0131rlatan Do\u00e7. Dr. G\u00fclcan Bulut, s\u00f6zlerine \u015f\u00f6yle devam etti: “Kansere ba\u011fl\u0131 \u00f6l\u00fcm oran\u0131 azaltmak gerekiyor. Tarama y\u00f6ntemi de bu a\u00e7\u0131dan \u00e7ok \u00f6nemli. Erken tespitten ziyade \u00f6l\u00fcm oran\u0131n\u0131 d\u00fc\u015f\u00fcrebiliyor muyuz? Kolorektal kanser de d\u00fczenli tarama yap\u0131larak \u00f6l\u00fcm oran\u0131 d\u00fc\u015f\u00fcr\u00fclebilen bir kanser t\u00fcr\u00fcd\u00fcr. O nedenle sa\u011f kal\u0131m a\u00e7\u0131s\u0131ndan bu taramalar\u0131n \u00f6nemi b\u00fcy\u00fckt\u00fcr” a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n
Genetik testler, a\u015f\u0131r\u0131 kayg\u0131ya neden olmamal\u0131
\n
Medicana International \u0130zmir Hastanesi Medikal Onkoloji B\u00f6l\u00fcm\u00fc\u2019nden Prof. Dr. L\u00fctfiye Demir, erken te\u015fhisin hayat kurtard\u0131\u011f\u0131n\u0131 vurgulayarak, tarama testlerinin d\u00fczenli yap\u0131lmas\u0131 gerekti\u011fine dikkat \u00e7ekti. “Meme kanseri en \u00e7ok 45-54 ya\u015f aras\u0131ndaki kad\u0131nlarda g\u00f6r\u00fcl\u00fcyor” diyen Prof. Dr. L\u00fctfiye Demir, “Bu ya\u015f grubundaki kad\u0131nlar\u0131n y\u0131lda bir kez mamografi ve meme ultrasonu yapt\u0131rmalar\u0131 gerekir. 54 ya\u015f sonras\u0131nda ise bu taramalar iki y\u0131l arayla yap\u0131labilir. Y\u00fcksek riskli bireyler aras\u0131nda; ailesinde erken ya\u015fta meme veya yumurtal\u0131k kanseri ge\u00e7mi\u015fi bulunanlar, yo\u011fun meme yap\u0131s\u0131na sahip olanlar ve kanser \u00f6nc\u00fcs\u00fc lezyonlar ta\u015f\u0131yanlar bulunuyor. \u00d6zellikle BRCA geni pozitif olanlar, yani kal\u0131tsal meme kanseri riski ta\u015f\u0131yan bireylerin meme kanserine yakalanma oran\u0131 y\u00fczde 80\u2019e kadar \u00e7\u0131kabiliyor. Genetik yatk\u0131nl\u0131\u011f\u0131 belirlemek i\u00e7in genetik testlerin 16 ya\u015f\u0131ndan sonra, tercihen 18-20 ya\u015f aras\u0131nda yap\u0131lmas\u0131 da \u00f6nemlidir” \u015feklinde g\u00f6r\u00fc\u015f verdi.<\/p>\n
21 ya\u015f\u0131ndan itibaren d\u00fczenli testler yapt\u0131r\u0131lmal\u0131
\n
Medicana International \u0130zmir Hastanesi Kad\u0131n Hastal\u0131klar\u0131 ve Do\u011fum B\u00f6l\u00fcm\u00fc\u2019nden Op. Dr. \u0130lkay Topalo\u011flu, rahim a\u011fz\u0131 kanserinin y\u00fczde 95 oran\u0131nda HPV vir\u00fcs\u00fcn\u00fcn yol a\u00e7t\u0131\u011f\u0131 kronik bir enfeksiyon sonucu geli\u015fti\u011fini belirterek, s\u00f6zlerini \u015f\u00f6yle s\u00fcrd\u00fcrd\u00fc: “Rahim a\u011fz\u0131 kanseri, erken tan\u0131 ile tedavi edilebilen bir kanser t\u00fcr\u00fcd\u00fcr. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 y\u0131llard\u0131r bu konuda halk sa\u011fl\u0131\u011f\u0131na y\u00f6nelik \u00f6nemli ad\u0131mlar atmaktad\u0131r. Eskiden sadece HPV 16 ve 18 t\u00fcrlerine kar\u015f\u0131 koruyan a\u015f\u0131lar\u0131n yerini art\u0131k 9\u2019lu a\u015f\u0131 alm\u0131\u015f durumdad\u0131r. T\u00fcrkiye\u2019de son 1.5 y\u0131ld\u0131r uygulamaya giren 9\u2019lu HPV a\u015f\u0131s\u0131, \u00e7ocuklar ve gen\u00e7ler i\u00e7in b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. \u00d6te yandan a\u015f\u0131 olunsa bile tarama programlar\u0131ndan sap\u0131lmamas\u0131 gerekmektedir. \u00c7\u00fcnk\u00fc a\u015f\u0131, yaln\u0131zca HPV\u2019nin neden oldu\u011fu kanserleri engellemektedir. Bu nedenle 21 ya\u015f\u0131ndan sonra her kad\u0131n d\u00fczenli olarak smear testi ve HPV testi yapt\u0131r\u0131lmal\u0131d\u0131r. Ki\u015finin rahmi al\u0131nm\u0131\u015fsa bile, rahim a\u011fz\u0131 b\u0131rak\u0131lm\u0131\u015fsa rahim a\u011fz\u0131 kanseri taramalar\u0131na devam edilmelidir. \u00c7\u00fcnk\u00fc vir\u00fcs, vajen b\u00f6lgesini de etkileyebilmektedir.”<\/p>\n
Tedavi s\u00fcreci gelece\u011fi d\u00fc\u015f\u00fcnerek planlanmal\u0131
\n
Medicana International \u0130zmir Hastanesi Radyasyon Onkolojisi B\u00f6l\u00fcm\u00fc\u2019nden Uzm. Dr. \u00c7imen Ak\u00e7ay, hastalar\u0131n tedavi s\u00fcrecinde yaln\u0131zca an\u0131 de\u011fil, gelece\u011fi de g\u00f6z \u00f6n\u00fcnde bulundurmalar\u0131 gerekti\u011fini belirterek, “Tedavi kapsam\u0131nda yap\u0131lan her \u015fey sadece bug\u00fcn\u00fc de\u011fil, bir ay sonras\u0131n\u0131, \u00fc\u00e7 ay sonras\u0131n\u0131, hatta 10, 15, 20 y\u0131l sonras\u0131n\u0131 kapsamaktad\u0131r. Bu nedenle hastalar\u0131n, hekimleriyle her zaman ileti\u015fimde kalmalar\u0131 \u00f6nemlidir. Onkoloji doktorlar\u0131 her konuda hastalara yard\u0131mc\u0131 olacaklard\u0131r. Ayr\u0131ca tedavi planlamas\u0131 uzun vadeli d\u00fc\u015f\u00fcn\u00fclerek yap\u0131lmaktad\u0131r. \u00c7\u00fcnk\u00fc as\u0131l ama\u00e7, an\u0131 kurtarmak de\u011fil, gelecek y\u0131llar\u0131 d\u00fc\u015f\u00fcnerek tedavi uygulamakt\u0131r” ifadelerini kulland\u0131.<\/p>\n
Kanser tedavisinde psikolojik destek ve yas s\u00fcreci
\n
Kanserin sadece bir hastal\u0131k de\u011fil, ayn\u0131 zamanda bir ya\u015fam \u015fekli de\u011fi\u015fikli\u011fi ve ki\u015finin ya\u015fad\u0131\u011f\u0131 \u2018normal\u2019 hayat\u0131n kayb\u0131 oldu\u011funu vurgulayan Medicana International \u0130zmir Hastanesi Psikiyatri B\u00f6l\u00fcm\u00fc\u2019nden Dr. \u00d6\u011fretim \u00dcyesi M\u00fcge Ya\u015far, “Ki\u015fi, kanser tan\u0131s\u0131 ald\u0131\u011f\u0131 andan itibaren yas d\u00f6nemi ba\u015flayabilmektedir. Hasta ilk ba\u015flarda “neden ben?” sorusunu sorar. \u00d6nce ink\u00e2r a\u015famas\u0131na sonra da kabullenme a\u015famas\u0131na ge\u00e7er. Onkolojik tedavi s\u00fcreci fiziksel oldu\u011fu kadar psikolojik bir s\u00fcre\u00e7tir. Bu anlamda kanser tedavisinde ruhsal iyile\u015fmenin de g\u00f6z ard\u0131 edilmemesi gerekir” dedi.<\/p>\n
Mamografi erken tan\u0131 i\u00e7in en g\u00fcvenilir ara\u00e7lardan biri
\n
Medicana International \u0130zmir Hastanesi\u2019ndeki kad\u0131n kanserleri s\u00f6yle\u015fisine konuk olan Radyoloji Uzman\u0131 Dr. Feraye Sara\u00e7o\u011flu da mamografinin zararl\u0131 oldu\u011funa ili\u015fkin yanl\u0131\u015f d\u00fc\u015f\u00fcncelerin varl\u0131\u011f\u0131na dikkat \u00e7ekerek, “Normalde bir insan y\u0131lda 2.3 milisivert radyasyona maruz kal\u0131yor. Bu, do\u011frudan yery\u00fcz\u00fcnden ve g\u00f6ky\u00fcz\u00fcnden gelen do\u011fal \u0131\u015f\u0131malardan kaynaklanmaktad\u0131r. Mamografide ise sadece 0.07 milisivert doz veriliyor. Bu, son derece d\u00fc\u015f\u00fck bir dozdur ve g\u00f6z ard\u0131 edilebilir. Mamografi, olduk\u00e7a g\u00fcvenli bir tarama y\u00f6ntemidir. T\u0131p tarihinde bir\u00e7ok y\u00f6ntem zamanla ortadan kalkt\u0131. Ya daha etkili y\u00f6ntemler bulundu ya da zararl\u0131 olduklar\u0131 ortaya \u00e7\u0131kt\u0131. Ancak mamografi 60 y\u0131ldan fazla s\u00fcredir aktif olarak kullan\u0131lmakta ve bug\u00fcne kadar herhangi bir zarar\u0131 kan\u0131tlanmam\u0131\u015ft\u0131r. Hala yerine ge\u00e7ebilecek bir ba\u015fka y\u00f6ntem de bulunmamaktad\u0131r. Bu y\u00fczden mamografi, kanserin erken evrelerinde tespiti i\u00e7in hala en g\u00fcvenilir ara\u00e7lardan biridir” diye konu\u015ftu.
<\/p>\n","protected":false},"excerpt":{"rendered":"
Kad\u0131n sa\u011fl\u0131\u011f\u0131 ve kanserle m\u00fccadelede fark\u0131ndal\u0131k olu\u015fturmak amac\u0131yla Medicana International \u0130zmir Hastanesi\u2019nde, “Kad\u0131n doktorlar kad\u0131n kanserlerini konu\u015fuyor” ba\u015fl\u0131kl\u0131 bir s\u00f6yle\u015fi d\u00fczenlendi. Medicana International \u0130zmir Hastanesi, \u2018Kad\u0131n doktorlar kad\u0131n kanserlerini konu\u015fuyor\u2019 ba\u015fl\u0131kl\u0131 s\u00f6yle\u015fiye ev sahipli\u011fi yapt\u0131 Medicana International \u0130zmir Hastanesi Medikal Onkoloji B\u00f6l\u00fcm\u00fc\u2019nden Do\u00e7. Dr. G\u00fclcan Bulut\u2019un moderat\u00f6rl\u00fc\u011f\u00fcn\u00fc yapt\u0131\u011f\u0131, onkoloji hastalar\u0131n\u0131n da kat\u0131ld\u0131\u011f\u0131 s\u00f6yle\u015fide, Medikal Onkoloji…<\/p>\n","protected":false},"author":1,"featured_media":26610,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-26609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/26609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26609"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/26609\/revisions"}],"predecessor-version":[{"id":26611,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/26609\/revisions\/26611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/26610"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}